Information Journal Paper
APA:
Copy. (2020). The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. BLOOD, 135(21), 1912-1915. SID. https://sid.ir/paper/780257/en
Vancouver:
Copy. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. BLOOD[Internet]. 2020;135(21):1912-1915. Available from: https://sid.ir/paper/780257/en
IEEE:
Copy, “The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients,” BLOOD, vol. 135, no. 21, pp. 1912–1915, 2020, [Online]. Available: https://sid.ir/paper/780257/en